Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1985 Nov;82(22):7757–7761. doi: 10.1073/pnas.82.22.7757

Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine.

H Y Yang, W Fratta, E A Majane, E Costa
PMCID: PMC391413  PMID: 3865193

Abstract

Two peptides that crossreact with an antiserum raised against Phe-Met-Arg-Phe-NH2 were purified from bovine brain extract. Their structures were determined to be Ala-Gly-Glu-Gly-Leu-Ser-Ser-Pro-Phe-Trp-Ser-Leu-Ala-Ala-Pro-Gln-Arg-Phe- NH2 and Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2. The sequences were determined by gas-phase sequencing, except for the COOH-terminal phenylalaninamides. These were assigned on the basis of the reactivity of the peptides with the anti-Phe-Met-Arg-Phe-NH2 antiserum, which appears to recognize the determinant -Arg-Phe-NH2. Both peptides were synthesized, and the synthetic peptides were found to have the same HPLC retention times as the endogenous Phe-Met-Arg-Phe-NH2-immunoreactive peptides, thus confirming the assignment of phenylalaninamide to the COOH-terminal positions. Both of the synthetic peptides were found to decrease tail-flick latency in rats, and the octapeptide was more active than the octadecapeptide. The octapeptide was found also to attenuate the prolongation of the tail-flick latency induced by morphine.

Full text

PDF
7757

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Contreras P. C., Takemori A. E. Antagonism of morphine-induced analgesia, tolerance and dependence by alpha-melanocyte-stimulating hormone. J Pharmacol Exp Ther. 1984 Apr;229(1):21–26. [PubMed] [Google Scholar]
  2. Dockray G. J., Reeve J. R., Jr, Shively J., Gayton R. J., Barnard C. S. A novel active pentapeptide from chicken brain identified by antibodies to FMRFamide. Nature. 1983 Sep 22;305(5932):328–330. doi: 10.1038/305328a0. [DOI] [PubMed] [Google Scholar]
  3. Dockray G. J., Vaillant C., Williams R. G. New vertebrate brain--gut peptide related to a molluscan neuropeptide and an opioid peptide. Nature. 1981 Oct 22;293(5834):656–657. doi: 10.1038/293656a0. [DOI] [PubMed] [Google Scholar]
  4. Faris P. L., Komisaruk B. R., Watkins L. R., Mayer D. J. Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia. Science. 1983 Jan 21;219(4582):310–312. doi: 10.1126/science.6294831. [DOI] [PubMed] [Google Scholar]
  5. Gayton R. J. Mammalian neuronal actions of FMRFamide and the structurally related opioid Met-enkephalin-Arg6-Phe7. Nature. 1982 Jul 15;298(5871):275–276. doi: 10.1038/298275a0. [DOI] [PubMed] [Google Scholar]
  6. Greenberg M. J., Painter S. D., Doble K. E., Nagle G. T., Price D. A., Lehman H. K. The molluscan neurosecretory peptide FMRFamide: comparative pharmacology and relationship to the enkephalins. Fed Proc. 1983 Jan;42(1):82–86. [PubMed] [Google Scholar]
  7. Hammonds R. G., Jr, Nicolas P., Li C. H. beta-endorphin-(1-27) is an antagonist of beta-endorphin analgesia. Proc Natl Acad Sci U S A. 1984 Mar;81(5):1389–1390. doi: 10.1073/pnas.81.5.1389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hökfelt T., Lundberg J. M., Tatemoto K., Mutt V., Terenius L., Polak J., Bloom S., Sasek C., Elde R., Goldstein M. Neuropeptide Y (NPY)- and FMRFamide neuropeptide-like immunoreactivities in catecholamine neurons of the rat medulla oblongata. Acta Physiol Scand. 1983 Feb;117(2):315–318. doi: 10.1111/j.1748-1716.1983.tb07214.x. [DOI] [PubMed] [Google Scholar]
  9. Kastin A. J., Olson R. D., Ehrensing R. H., Berzas M. C., Schally A. V., Coy D. H. MIF-I's differential actions as an opiate antagonist. Pharmacol Biochem Behav. 1979 Dec;11(6):721–723. doi: 10.1016/0091-3057(79)90270-3. [DOI] [PubMed] [Google Scholar]
  10. Moore R. Y., Gustafson E. L., Card J. P. Identical immunoreactivity of afferents to the rat suprachiasmatic nucleus with antisera against avian pancreatic polypeptide, molluscan cardioexcitatory peptide and neuropeptide Y. Cell Tissue Res. 1984;236(1):41–46. doi: 10.1007/BF00216511. [DOI] [PubMed] [Google Scholar]
  11. Price D. A., Greenberg M. J. Structure of a molluscan cardioexcitatory neuropeptide. Science. 1977 Aug 12;197(4304):670–671. doi: 10.1126/science.877582. [DOI] [PubMed] [Google Scholar]
  12. Smock T., Fields H. L. ACTH1-24 blocks opiate - induced analgesia in the rat. Brain Res. 1981 May 11;212(1):202–206. doi: 10.1016/0006-8993(81)90052-4. [DOI] [PubMed] [Google Scholar]
  13. Tang J., Yang H. Y., Costa E. Inhibition of spontaneous and opiate-modified nociception by an endogenous neuropeptide with Phe-Met-Arg-Phe-NH2-like immunoreactivity. Proc Natl Acad Sci U S A. 1984 Aug;81(15):5002–5005. doi: 10.1073/pnas.81.15.5002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Weber E., Evans C. J., Samuelsson S. J., Barchas J. D. Novel peptide neuronal system in rat brain and pituitary. Science. 1981 Dec 11;214(4526):1248–1251. doi: 10.1126/science.7029714. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES